Chronic Kidney Disease on Hemodialysis
12
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Experience of Young Adult Kidney Patients Requiring Haemodialysis
Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal
Outcomes of Renal Replacement in Mexico
Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients
Restorative and Supportive Meals at HomeCare
The Effect of Geranium Essential Oil Aromatherapy on Fatigue and Sleep Quality in Patients Undergoing Hemodialysis
The Self-management Program on Hemodialysis Patients in Cambodia
The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients
Arteriovenous Fistula Cannulation Pain and Skin Cooling Device
Quantification of Autonomic Nervous Activity During Hemodialysis
Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis
Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis